Idian Duo Tablet 5/1000 mg
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.
MFDS item code 202201338 · Approved 2022.04.04
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used to improve blood sugar control in adults with type 2 diabetes by combining empagliflozin and metformin alongside dietary and exercise therapy. It is suitable for patients whose blood sugar is not adequately controlled, and caution should be exercised when used in patients with concomitant cardiovascular disease under the guidance of a professional. This medication helps in blood sugar management and contributes to the overall health improvement of patients.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients whose blood glucose is not adequately controlled with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; in this case, skip the missed dose. Special Populations Patients with Renal Impairment No dose adjustment is required for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily, so treatment should be initiated with the individual single-ingredient products empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Do not administer to the following patients, item 2)). Elderly Patients In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication is helpful in lowering blood sugar. However, a rare side effect called severe lactic acidosis may occur, which can be very dangerous, so caution is advised. When used in conjunction with other diabetes medications, there is a risk of hypoglycemia, so symptoms should be monitored closely. Patients with severely impaired kidney function, acute kidney issues, severe infections, or heart failure should not use this medication. The use of this medication should be temporarily discontinued before and after tests involving radiopaque agents, and it should be resumed only after kidney function is confirmed to be normal. Pregnant or breastfeeding women should refrain from using this medication for safety。 During the use of this medication, regular kidney function tests should be conducted, and special caution should be taken in states where there is a risk of fluid loss. Hypoglycemic symptoms may occur, so meals should not be skipped, and it should be taken regularly, and dosage adjustments may be necessary when used with insulin or other blood sugar-lowering agents. This medication may increase the risk of urinary tract infections or genital infections, so immediate consultation with a physician is necessary if related symptoms appear. Vitamin B12 levels may decrease, so it is advisable to check through blood tests during prolonged use. Alcohol consumption may increase the risk of side effects from this medication, so it is best to avoid it. If eating is difficult due to surgery or serious illness, the use of this medication should be temporarily stopped and resumed once the patient has recovered. If any unusual symptoms or discomfort occur while taking this medication, immediate consultation with medical staff is required.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture infiltration, and it is safe to store at room temperatures between 1°C and 30°C. Proper storage will help maintain the medication's effectiveness for a longer duration.
Biconvex oval film-coated tablet with a yellow color having a brownish tint
10 tablets/box (10 tablets x 1), 60 tablets/box (10 tablets x 6), 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.